SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3924Ashcroft just gave a major biggie presentation regarding terror. He said that escaram(o)uche5/26/2004
3923Altus Raises $51 Million in Series C Financing CAMBRIDGE, Mass.--(BUSINESS WIREnigel bates5/25/2004
3922British vaccine firm Microscience joins IPO wave By Ben Hirschler and Steve Slanigel bates5/24/2004
3921Rick...ouch...that's a toughie...I can see both sides of the argument...woulzeta19615/21/2004
3920Patent on Test for Cancer Is Revoked by Europe By ANDREW POLLACK Published: Mayscaram(o)uche5/20/2004
3919Rick, seems like much bio-earmarked $$ are on the sidelines...PHRM's approvazeta19615/20/2004
3918"supply is high"......... Message 20147899 Hamilton is always good. scaram(o)uche5/20/2004
3917Senate OKs $5.6B for Chemical Attacks Wednesday May 19, 5:01 pm ET By Jesse J. scaram(o)uche5/19/2004
3916Biotech, vaccine stocks rise on BioShield bill Reuters, 05.19.04, 3:31 PM ET NEscaram(o)uche5/19/2004
3915SkyePharma and Endo Announce FDA Approval of DepoDur(TM) (previously referred toscaram(o)uche5/19/2004
3914Elan and Biogen Idec Announce Results from Phase III Maintenance Trial of ANTEGRscaram(o)uche5/18/2004
3913forbes.com <b>Gilead Takes On Glaxo</b> Zina Moukheiber, 05.17.04, scaram(o)uche5/17/2004
3912i.e., don't get too fancy or too greedy, after landing some lunkers. thanksscaram(o)uche5/17/2004
3911BVF 13-HF <pre> 3/31/2004 michael_f_murphy5/17/2004
3910Bristol-Myers Squibb, Gilead Sciences and Merck & Co., Inc. Announce Plans tscaram(o)uche5/16/2004
3909Targacept files with SEC for $86.25 mln IPO Friday May 14, 5:39 pm ET NEW YORKscaram(o)uche5/14/2004
3908<<Sort of a call option. Big money held back until the option is exercisedMiljenko Zuanic5/12/2004
3907It's great for the private BT company as well, since venture investors can qkeokalani'nui5/12/2004
3906What's also interesting about the Roche/Syrrx deal is it seems Roche has crerkrw5/12/2004
3905finance.yahoo.com not a shareholder. :-( BioSante Pharmaceuticals Announces $scaram(o)uche5/12/2004
3904Syrrx is an example of a big-science private company that attracted a then-good scaram(o)uche5/12/2004
3903>> A lot of money for an early stage << Syrrx cut a deal today.....scaram(o)uche5/12/2004
3902Amicus Therapeutics Raises $31 Million in Series B Financing <i>A lot of nigel bates5/12/2004
3901Some companies that don't deserve cash are thumbing nose at current shareholscaram(o)uche5/12/2004
3900CVTX taps the convertible market, and the stock takes a hit... Message 20120414mopgcw5/12/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News